Find the Perfect Plan for Your Investment Journey
I
Latest price
52 Week Range
€1.43 - €3.67
Next Earnings Date
Sep 23 2025 (Estimate)
Next Earnings Date
Sep 23 2025 (Est.)
Latest price
Market Cap | €302.29M |
EV | €386.63M |
Shares Outstanding | 95.67M |
Beta | 0.99 |
Analyst Rating | BUY |
Analyst Target Price | €6.30 |
P/E 2025E | - |
P/Revenue 2025E | 20.73x |
Revenue | 29.90% |
EPS | -35.30% |
Operating Cash Flow | -21.80% |
Free Cash Flow | -21.40% |
Revenue | 14.70% |
EPS | 34.40% |
Operating Cash Flow | 11.00% |
Free Cash Flow | - |
Gross Margin 2025E | 100.00% |
Net Profit Margin 2025E | -668.45% |
ROE 2025E | 1087.56% |
ROCE 2024 | - |
DPS 2025E | €0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
I
Inventiva S.A.
IVA
Sector
Healthcare
Industry
Biotechnology
CEO
Cren, Frederic
Employees
116
Website
www.inventivapharma.comIPO Date
2017-02-15
Headquarters
50 rue de Dijon, Daix, Burgundy, 21121, France
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved